Diagnosis and treatment of multidrug-resistant tuberculosis
Tuberculosis (TB) is still a major health problem worldwide. Especially, multidrug-resistant TB (MDR-TB), which is defined as TB that shows resistance to both isoniazid and rifampicin, is a barrier in the treatment of TB. Globally, approximately 3.4% of new TB patients and 20% of the patients with a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Yeungnam University College of Medicine
2020-10-01
|
| Series: | Yeungnam University Journal of Medicine |
| Subjects: | |
| Online Access: | http://www.e-yujm.org/upload/pdf/yujm-2020-00626.pdf |